We are buying 55 shares of Abbott Laboratories at roughly $100.89 and 200 shares of Coterra Energy at roughly $27.44. Following the trades, Jim Cramer's Charitable Trust will own 950 shares of ABT, increasing its weighting to 3.00% from 2.84% and 3,100 shares of CTRA, increasing its weighting to 2.65% from 2.48%. We're putting some cash to work into the down open Wednesday. Once again, we are adding to our position in Abbott Labs.
We continue to believe this disconnect creates an opportunity to slowly buy this Dividend Aristocrat on weakness. We're adding to Coterra because we want to more energy exposure on our books due to the rising geopolitical tensions in the Middle East. Coterra Energy has been our long preferred name due to its capital efficiency and ability to flex investment between oil and natural gas – whatever is most economical based on commodity prices.